Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 - Franck Rapaport; Kenneth Seier; Yaseswini Neelamraju; Duane Hassane; Timour Baslan; Daniel T. Gildea; Samuel Haddox; Tak Lee; H. Moses Murdock; Caroline Sheridan; Alexis Thurmond; Ling Wang; et al. (Blood Cancer Journal, 2022)